JO
Rating #60
Johnson & Johnson
Portfolio value
Stocks
Performance
1 Year
+56.89%
Stock Holdings
$
%
1Y
3Y
5Y
10Y
Top10 stocks: 98.34% of the portfolio
Adds
New Buys
Sold Outs
Cuts
Company Name | Primary Industry | Avg. price paid | Share Count Chg. (%) | No of shares held | Market value | Portfolio % Change | % of Ownership | Holding period | Last Transaction | |
|---|---|---|---|---|---|---|---|---|---|---|
1 ![]() PTGX | Pharmaceutical Pres | $17.72 | 0.00% | 2.45M | $213.91M | 38.54% 6.42ppt | 3.84% | 18 Quarters | Q3 2021 | |
2 ![]() NBTX | Pharmaceutical Pres | $7.53 | 0.00% | 5.62M | $130.02M | 23.43% 2.45ppt | 11.86% | 10 Quarters | Q4 2023 | |
3 ![]() RAPP | Pharmaceutical Pres | $25.44 | 0.00% | 1.78M | $54.14M | 9.75% -0.71ppt | 4.70% | 7 Quarters | Q3 2025 | |
4 ![]() MGTX | Biological products | $9.43 | 0.00% | 6.64M | $52.80M | 9.51% -1.28ppt | 8.20% | 18 Quarters | Q4 2022 | |
5 ![]() CVRX | Surgical Instruments | $16.75 | Cut -1.91% | 4.02M | $28.58M | 5.15% -1.39ppt | 15.35% | 18 Quarters | Q4 2025 | |
6 ![]() CTNM | Pharmaceutical Pres | $21.00 | 0.00% | 1.98M | $22.62M | 4.08% -0.52ppt | 7.04% | 7 Quarters | Q2 2024 | |
7 ![]() LEGN | Pharmaceutical Pres | $50.56 | 0.00% | 814.59K | $17.71M | 3.19% -2.05ppt | 0.90% | 18 Quarters | Q2 2023 | |
8 ![]() XNCR | Pharmaceutical Pres | $40.12 | 0.00% | 748.06K | $11.45M | 2.06% 0.33ppt | 1.01% | 17 Quarters | Q4 2021 | |
9 ![]() PRCT | Surgical Instruments | $38.15 | 0.00% | 357.94K | $11.26M | 2.03% -0.49ppt | 0.64% | 18 Quarters | Q4 2022 | |
10 ![]() FATE | Biological products | $59.27 | 0.00% | 3.38M | $3.32M | 0.60% -0.24ppt | 2.84% | 18 Quarters | Q3 2021 | |
11 ![]() NMRA | Biological products | $15.60 | 0.00% | 1.85M | $3.31M | 0.60% -0.07ppt | 1.14% | 10 Quarters | Q4 2023 | |
12 ![]() RLYB | Pharmaceutical Pres | $1.36 | 0.00% | 3.64M | $2.49M | 0.45% 0.09ppt | 8.07% | 7 Quarters | Q2 2024 | |
13 ![]() LYEL | Pharmaceutical Pres | $16.24 | 0.00% | 54.89K | $1.69M | 0.30% 0.13ppt | 0.30% | 2 Quarters | Q3 2025 | |
14 ![]() VOR | Biological products | $48.72 | 0.00% | 53.73K | $702.82K | 0.13% -0.39ppt | 0.80% | 2 Quarters | Q3 2025 | |
15 ![]() NNOX | X-Ray Apparatus | $11.10 | 0.00% | 158.85K | $444.79K | 0.08% -0.04ppt | 0.25% | 17 Quarters | Q1 2024 | |
16 ![]() LAB | Lab Analytical Instruments | $2.70 | 0.00% | 311.97K | $399.32K | 0.07% -0.01ppt | 0.08% | 8 Quarters | Q1 2024 | |
17 ![]() ACET | Pharmaceutical Pres | $8.42 | New Buy +100.00% | 22.78K | $191.80K | 0.03% 0.03ppt | 0.40% | 1 Quarter | Q4 2025 |
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data Providers